Gossamer Bio (GOSS) Total Assets by Year
Gossamer Bio closed fiscal year 2025 with $172.2M in total assets, $295.0M in total liabilities and -$122.8M in shareholder equity. This represents a decrease of 45.4% from the prior fiscal year. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Gossamer Bio has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
GOSS Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $172.2M-45.4% | $315.3M+1.1% | $311.9M+14.5% | $272.4M-20.7% | $343.7M-36.3% | $539.4M+26.4% | $426.6M+78.2% | $239.4M | N/A |
| Total Liabilities | $295.0M+3.2% | $285.8M+14.7% | $249.1M-4.3% | $260.4M+17.2% | $222.2M+1.6% | $218.7M+195.1% | $74.1M-79.4% | $359.5M | N/A |
| Total Equity | -$122.8M-516.2% | $29.5M-53.0% | $62.8M+419.7% | $12.1M-90.1% | $121.5M-62.1% | $320.7M-9.0% | $352.5M+393.6% | -$120.1M-1649.8% | -$6.9M |
GOSS Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $76.9M-68.1% | $128.9M-54.1% | $172.2M-45.4% | $208.8M-40.5% | $240.9M-35.5% | $280.6M+8.2% | $315.3M+1.1% | $350.9M+0.8% | $373.4M+105.5% | $259.4M+17.9% | $311.9M+14.5% | $347.9M+7.5% |
| Total Liabilities | $170.9M-40.5% | $290.4M+1.2% | $295.0M+3.2% | $291.2M-1.9% | $287.0M-1.7% | $286.8M+23.3% | $285.8M+14.7% | $296.7M+22.0% | $291.9M+19.4% | $232.6M-6.3% | $249.1M-4.3% | $243.3M-8.9% |
| Total Equity | -$94.0M-103.9% | -$161.5M-2483.7% | -$122.8M-516.2% | -$82.3M-252.1% | -$46.1M-156.6% | -$6.3M-123.4% | $29.5M-53.0% | $54.1M-48.3% | $81.5M+229.8% | $26.7M+193.9% | $62.8M+419.7% | $104.6M+85.7% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Gossamer Bio financials
Frequently Asked Questions
What was Gossamer Bio's total assets in fiscal year 2025?
Gossamer Bio closed fiscal year 2025 with $172.2M in total assets, $295.0M in total liabilities and -$122.8M in shareholder equity.
How fast is Gossamer Bio's total assets growing?
Gossamer Bio (GOSS) total assets fell by 45.4% year over year, from $315.3M to $172.2M in fiscal year 2025.
What was Gossamer Bio's total assets in the most recent quarter?
Gossamer Bio (GOSS) reported $76.9M in total assets in Q2 2026. This represents a decrease of 68.1% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Gossamer Bio (GOSS) reported on that line in every period on record.